Related Experiment Video
Updated: Jun 23, 2026

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction
Published on: May 17, 2024
The role of ADAMs in disease pathophysiology
Michael J Duffy1, Eadaoin McKiernan, Norma O'Donovan
1Department of Pathology and Laboratory Medicine, St. Vincent's University Hospital, Dublin 4, Ireland. Michael.J.Duffy@ucd.ie
Abstract:
The ADAMs are a family of multidomain transmembrane and secreted proteins involved in both proteolysis and cell adhesion. Altered expression of specific ADAMs is implicated in the pathophysiology of several diseases including rheumatoid arthritis, Alzheimer's disease, cardiac hypertrophy, asthma and cancer. Of these different diseases, it is in cancer where most research has been carried out. Multiple ADAMs, including ADAM-9, ADAM-10, ADAM-12, ADAM-15 and ADAM-17, have been shown to play a role in either cancer formation or progression. Consistent with these findings, increased expression of specific ADAMs in several cancer types was found to correlate with features of aggressive disease and poor prognosis. Currently, selective ADAM inhibitors against ADAM-10 and ADAM-17 are undergoing clinical trials for the treatment of cancer. Further work is required in order to establish a causative role for ADAMs in rheumatoid arthritis, Alzheimer's disease, cardiac hypertrophy and asthma.
Insights
ADAM proteins are crucial in cell adhesion and proteolysis, with altered expression linked to diseases like cancer. Research highlights specific ADAMs
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- ADAMs (a disintegrin and metalloproteinase domain) are multidomain proteins involved in proteolysis and cell adhesion.
- Altered expression of ADAMs is implicated in various diseases, including cancer, rheumatoid arthritis, Alzheimer's disease, cardiac hypertrophy, and asthma.
Purpose of the Study:
- To review the role of ADAM proteins in disease pathophysiology, with a focus on their involvement in cancer.
- To summarize current research on ADAMs in cancer formation and progression.
- To highlight the therapeutic potential of ADAM inhibitors in cancer treatment.
Main Methods:
- Literature review of studies investigating ADAM protein expression and function in various diseases.
- Analysis of correlations between ADAM expression levels and disease severity or prognosis.
- Examination of ongoing clinical trials for ADAM inhibitors in cancer therapy.
Main Results:
- Multiple ADAMs (ADAM-9, ADAM-10, ADAM-12, ADAM-15, ADAM-17) are implicated in cancer development and progression.
- Increased expression of specific ADAMs in cancers correlates with aggressive disease and poor prognosis.
- Selective ADAM inhibitors targeting ADAM-10 and ADAM-17 are in clinical trials for cancer treatment.
Conclusions:
- ADAM proteins play a significant role in cancer pathophysiology.
- Targeting ADAMs presents a promising therapeutic strategy for cancer.
- Further research is needed to elucidate the causative roles of ADAMs in rheumatoid arthritis, Alzheimer's disease, cardiac hypertrophy, and asthma.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Introduction to Language of Pathophysiology l
Parkinson Disease ll: Pathophysiology
Coronary Artery Disease II: Pathophysiology
Introduction to Language of Pathophysiology ll
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results from...
